ATE251630T1 - Phosphinic pseudopeptide als matrix metalloprotease-inhibitoren - Google Patents

Phosphinic pseudopeptide als matrix metalloprotease-inhibitoren

Info

Publication number
ATE251630T1
ATE251630T1 AT00900598T AT00900598T ATE251630T1 AT E251630 T1 ATE251630 T1 AT E251630T1 AT 00900598 T AT00900598 T AT 00900598T AT 00900598 T AT00900598 T AT 00900598T AT E251630 T1 ATE251630 T1 AT E251630T1
Authority
AT
Austria
Prior art keywords
amino acid
natural
metalloprotease inhibitors
lateral chain
pseudopeptides
Prior art date
Application number
AT00900598T
Other languages
English (en)
Inventor
Paul Di Basset
Vincent Dive
Philippe Cuniasse
Marie-Christine Rio
Athanasios Yotakis
Fabrice Beau
Stamania Vassiliou
Original Assignee
Commissariat Energie Atomique
Inst Nat Sante Rech Med
Centre Nat Rech Scient
Basset Genevieve Lf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique, Inst Nat Sante Rech Med, Centre Nat Rech Scient, Basset Genevieve Lf filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of ATE251630T1 publication Critical patent/ATE251630T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
AT00900598T 1999-01-19 2000-01-18 Phosphinic pseudopeptide als matrix metalloprotease-inhibitoren ATE251630T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900509A FR2788525B1 (fr) 1999-01-19 1999-01-19 Pseudo-peptides phosphiniques, utilisables comme inhibiteurs des metalloproteases a zinc matricielles
PCT/FR2000/000093 WO2000043404A1 (fr) 1999-01-19 2000-01-18 Pseudo-peptides phosphiniques inhibiteurs des metalloproteases matricielles

Publications (1)

Publication Number Publication Date
ATE251630T1 true ATE251630T1 (de) 2003-10-15

Family

ID=9540989

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00900598T ATE251630T1 (de) 1999-01-19 2000-01-18 Phosphinic pseudopeptide als matrix metalloprotease-inhibitoren

Country Status (10)

Country Link
US (1) US6630501B1 (de)
EP (1) EP1144421B1 (de)
JP (1) JP2003517450A (de)
AT (1) ATE251630T1 (de)
CA (1) CA2360787A1 (de)
DE (1) DE60005788T2 (de)
DK (1) DK1144421T3 (de)
ES (1) ES2208260T3 (de)
FR (1) FR2788525B1 (de)
WO (1) WO2000043404A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922577D0 (en) * 1999-09-23 1999-11-24 Center For Clinical & Basic Re Substituted phosphinate based peptide derivatives
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
PL1685142T3 (pl) * 2003-11-11 2008-06-30 Hoffmann La Roche Pochodne kwasu fosfinowego, inhibitory beta-sekterazy do leczenia choroby Alzheimera
US20080125354A1 (en) * 2005-11-21 2008-05-29 Florida Atlantic University Selective inhibition of matrix metalloproteinases
FR2996003B1 (fr) 2012-09-25 2014-10-17 Commissariat Energie Atomique Methode pour detecter specifiquement dans un echantillon une metalloprotease matricielle (mmp) d'interet uniquement dans sa forme active
TWI743023B (zh) * 2014-05-21 2021-10-21 日商Ｋｍ生物醫藥股份有限公司 基質金屬蛋白酶 7(mmp-7)聚集體之單體化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676059B1 (fr) * 1991-05-02 1993-07-23 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteurs de collagenases bacteriennes.
JPH07503016A (ja) * 1992-01-15 1995-03-30 メルク　エンド　カンパニー　インコーポレーテッド 変形防止剤としての置換されたホスフィン酸含有ペプチジル誘導体
FR2689764B1 (fr) 1992-04-10 1995-05-12 Commissariat Energie Atomique Utilisation de dérivés de peptides pour la fabrication de médicaments inhibiteurs des endopeptidases 24.15 et 24.16.
FR2730235A1 (fr) 1995-02-06 1996-08-09 Commissariat Energie Atomique Nouveaux derives de peptides utilisables comme inhibiteur de l'endopeptidase a zinc 24-15
DK0923585T3 (da) * 1996-07-18 2002-07-01 Pfizer Phosphinatbaserede inhibitorer af matrixmetalloproteinaser

Also Published As

Publication number Publication date
DE60005788T2 (de) 2004-08-19
US6630501B1 (en) 2003-10-07
EP1144421A1 (de) 2001-10-17
FR2788525A1 (fr) 2000-07-21
DK1144421T3 (da) 2004-02-16
WO2000043404A1 (fr) 2000-07-27
DE60005788D1 (en) 2003-11-13
CA2360787A1 (fr) 2000-07-27
ES2208260T3 (es) 2004-06-16
JP2003517450A (ja) 2003-05-27
EP1144421B1 (de) 2003-10-08
FR2788525B1 (fr) 2002-11-29

Similar Documents

Publication Publication Date Title
CA2306313A1 (en) Dipeptide nitriles
BR0210504A (pt) Derivados de naftil-indol substituidos, atuantes como inibidores do inibidor tipo 1 (pai-1) do ativador de plasminogênio
IL129238A0 (en) N-(aryl/heteroarylacetyl) amino acid esters pharmaceutical compositions comprising same and methods for inhibiting b-amyloid peptide release and/ or its synthesis by use of such compounds
ES2079187T3 (es) Utilizacion de composiciones a base de policondensados de acido silicico modificados con radicales organicos, para el revestimiento de dientes y partes de protesis dentales.
MY135057A (en) Dolastatin 15 derivatives
NZ326238A (en) Compositons and methods for inhibiting nonenzymatic cross-linking and glycosylation (protein aging) using N-acylaminoalkylhydrazine carboximidamides
ATE383160T1 (de) Phosphinsäurederivate, inhibitoren von beta- sekretase zur behandlung von alzheimer-krankheit
JPS57212157A (en) Collagenase inhibitory compound
CY1107990T1 (el) Τριπεπτιδια και παραγωγα τριπεπτιδιων για τη θepαπεια νευροεκφυλιστικων ασθενειων
ATE251630T1 (de) Phosphinic pseudopeptide als matrix metalloprotease-inhibitoren
ATE357456T1 (de) Mittel zur förderung von knochenbildung
ES2184096T3 (es) Metodo para producir peptidos.
BR9812767A (pt) Complexos metálicos de 1-metil éster de n-[n-(3,3-dimetilbutil)-l-alfa-aspartil]-l-fenilalanina
FI956055A0 (fi) Tekijä VII:sta johdettuja peptidejä
AU4663301A (en) Method for preparing (2S,3R,4S)-4-hydroxyisoleucine and analogues thereof
MX2023005772A (es) Tetrapeptido y composiciones que comprenden tetrapeptidos.
EA200400603A1 (ru) Новые пептиды - аналоги гормона высвобождения гормона роста человека
RU2010145158A (ru) Производные опиорфинного пептида как потенциальные ингибиторы эктопептидаз, участвующих в деградации энкефалинов
ATE285244T1 (de) Tripeptide und deren derivate zur behandlung von postläsionalen krankheiten des nervensystems
Chen et al. Phosphonamidate based inhibitors of angiotensin-converting enzyme (ACE)
Green et al. Substrate related O, O-dialkyldipeptidyly ψ carboxybenzylphosphonates, a new type of thrombin inhibitor
ATE302783T1 (de) Phosphinsäure pseudo-peptidderivate
ATE342250T1 (de) Verfahren zur herstellung von (aminomethyl)trifluoromethylcarbinol-derivaten
BRPI0413743A (pt) inibidores de catepsina s
AU2003275889A1 (en) Phosphinic acid analogs of glutamate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties